HK1211955A1 - 阿立呱唑半抗原的抗體及其用途 - Google Patents
阿立呱唑半抗原的抗體及其用途Info
- Publication number
- HK1211955A1 HK1211955A1 HK15112824.0A HK15112824A HK1211955A1 HK 1211955 A1 HK1211955 A1 HK 1211955A1 HK 15112824 A HK15112824 A HK 15112824A HK 1211955 A1 HK1211955 A1 HK 1211955A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antibodies
- aripiprazole haptens
- aripiprazole
- haptens
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/302—Schizophrenia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261691544P | 2012-08-21 | 2012-08-21 | |
PCT/US2013/055780 WO2014031635A1 (en) | 2012-08-21 | 2013-08-20 | Antibodies to aripiprazole haptens and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1211955A1 true HK1211955A1 (zh) | 2016-06-03 |
Family
ID=50148306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15112824.0A HK1211955A1 (zh) | 2012-08-21 | 2015-12-30 | 阿立呱唑半抗原的抗體及其用途 |
Country Status (8)
Country | Link |
---|---|
US (4) | US9611332B2 (zh) |
EP (1) | EP2888285B1 (zh) |
JP (2) | JP6389176B2 (zh) |
CN (2) | CN104736567B (zh) |
AU (2) | AU2013305970B2 (zh) |
CA (1) | CA2882492C (zh) |
HK (1) | HK1211955A1 (zh) |
WO (1) | WO2014031635A1 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7297256B2 (en) | 2004-01-29 | 2007-11-20 | Fleet Guard, Inc. | Pressure gradient dosing system for fluid supply |
TR201816416T4 (tr) | 2012-08-21 | 2018-11-21 | Janssen Pharmaceutica Nv | Risperidona yönelik antikorlar ve bunların kullanımı. |
CN104755928B (zh) | 2012-08-21 | 2017-05-10 | 詹森药业有限公司 | 奥氮平的抗体及其用途 |
PT2888234T (pt) | 2012-08-21 | 2018-02-22 | Janssen Pharmaceutica Nv | Haptenos de aripiprazol e seu uso em imunoensaios |
CA2882490A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc. | Antibodies to paliperidone and use thereof |
JP6374387B2 (ja) | 2012-08-21 | 2018-08-15 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドンハプテンへの抗体及びその使用 |
WO2014031665A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to quetiapine haptens and use thereof |
JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
CN104736567B (zh) | 2012-08-21 | 2019-09-03 | 詹森药业有限公司 | 阿立哌唑半抗原的抗体及其用途 |
US20140057303A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Antibodies to Olanzapine Haptens and Use Thereof |
CA2882615C (en) | 2012-08-21 | 2019-07-09 | Ortho-Clinical Diagnostics, Inc. | Antibodies to quetiapine and use thereof |
ES2762105T3 (es) | 2012-08-21 | 2020-05-22 | Janssen Pharmaceutica Nv | Anticuerpos para aripiprazol y uso de los mismos |
WO2017106508A1 (en) | 2015-12-17 | 2017-06-22 | Janssen Pharmaceutica Nv | Antibodies to quetiapine and use thereof |
CA3008809A1 (en) | 2015-12-17 | 2017-06-22 | Janssen Pharmaceutica Nv | Antibodies to risperidone and use thereof |
JP2019113425A (ja) * | 2017-12-25 | 2019-07-11 | Blue Industries株式会社 | イムノクロマトアッセイ用検査カートリッジ及び検査装置 |
CN114685400B (zh) * | 2020-12-25 | 2023-11-10 | 长沙博源医疗科技有限公司 | 一种阿立哌唑关键基团衍生物、免疫原、抗阿立哌唑特异性抗体及其制备方法与应用 |
CN115792075B (zh) * | 2021-09-10 | 2023-11-03 | 江苏瑞科生物技术股份有限公司 | 4′-单磷酰脂质a类化合物的检测方法 |
CN115181076B (zh) * | 2022-06-24 | 2023-03-24 | 北京丹大生物技术有限公司 | 一种用于检测阿立哌唑和脱氢阿立哌唑浓度的半抗原、抗原、细胞株、抗体、试剂和试剂盒 |
CN116354904B (zh) * | 2023-04-26 | 2023-08-01 | 北京丹大生物技术有限公司 | 一种喹硫平衍生物半抗原、抗原、抗喹硫平抗体及其应用 |
Family Cites Families (102)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
US6893625B1 (en) | 1986-10-27 | 2005-05-17 | Royalty Pharma Finance Trust | Chimeric antibody with specificity to human B cell surface antigen |
EP1248112A3 (en) | 1987-04-27 | 2004-08-25 | Inverness Medical Switzerland GmbH | Immunochromatographic specific binding assay device |
US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
AU2684488A (en) | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
US5252496A (en) | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
US6034078A (en) | 1992-05-29 | 2000-03-07 | Eli Lilly And Company Limited | Thienobenzodiazepine compounds |
NZ247703A (en) | 1992-05-29 | 1995-07-26 | Lilly Industries Ltd | Thienobenzdiazepine derivatives and medicaments thereof |
US5527709A (en) | 1992-06-26 | 1996-06-18 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassays with labeled thyronine hapten analogues |
ATE176329T1 (de) | 1992-06-26 | 1999-02-15 | Johnson & Johnson Clin Diag | Immunotests unter verwendung von markierten thyronin-analogen |
US5642870A (en) | 1992-08-05 | 1997-07-01 | Sargis; Ike | Switch stand |
US5395933A (en) | 1992-08-07 | 1995-03-07 | Eastman Kodak Company | Carbamazepine hapten analogues |
JPH07247271A (ja) | 1994-01-21 | 1995-09-26 | Otsuka Pharmaceut Co Ltd | 3,4−ジヒドロカルボスチリル誘導体 |
EP0804580B1 (en) | 1994-06-10 | 2008-10-08 | Oklahoma Medical Research Foundation | Calcium binding recombinant antibody against protein c |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US5908781A (en) * | 1996-02-20 | 1999-06-01 | The United States Of America As Represented By The Secretary Of Agriculture | Monoclonal antibodies to ceftiofur |
US5761894A (en) | 1996-09-25 | 1998-06-09 | Magic Circle Corporation | Grass striping attachment for lawn mowers |
US6986890B1 (en) | 1996-11-21 | 2006-01-17 | Kyowa Hakko Kogyo Co., Ltd. | Anti-human VEGF receptor Flt-1 monoclonal antibody |
WO1998059233A1 (en) | 1997-06-23 | 1998-12-30 | Luminex Corporation | Interlaced lasers for multiple fluorescence measurement |
US6830731B1 (en) | 1998-01-05 | 2004-12-14 | Biosite, Inc. | Immunoassay fluorometer |
US6541669B1 (en) | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
US20030143233A1 (en) | 1999-06-07 | 2003-07-31 | Neorx Corporation | Streptavidin expressed gene fusions and methods of use thereof |
UA76708C2 (uk) | 1999-12-08 | 2006-09-15 | Сінгента Патисипейшонс Аг | Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду |
US7163681B2 (en) | 2000-08-07 | 2007-01-16 | Centocor, Inc. | Anti-integrin antibodies, compositions, methods and uses |
US6958156B2 (en) | 2000-12-15 | 2005-10-25 | Vyrex Corporation | Isoflavone derivatives |
US7157561B2 (en) * | 2001-07-13 | 2007-01-02 | Roche Diagnostics Operations, Inc. | Methods of inhibiting transmission of a costimulatory signal of lymphocytes |
ATE492565T1 (de) * | 2002-01-31 | 2011-01-15 | Randox Lab Ltd | Immunogene, antikörper und konjugate für ketamin und dessen metaboliten |
ATE482719T1 (de) | 2002-02-21 | 2010-10-15 | Univ Duke | Behandlungsverfahren unter verwendung von anti- cd22-antikörpern |
AU2003217676B2 (en) | 2002-02-22 | 2009-06-11 | Takeda Pharmaceutical Company Limited | Active agent delivery systems and methods for protecting and administering active agents |
DE60325184D1 (de) | 2002-03-01 | 2009-01-22 | Immunomedics Inc | Rs7 antikörper |
CA2479932A1 (en) | 2002-03-28 | 2003-10-09 | Eli Lilly And Company | Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
SE0201738D0 (sv) | 2002-06-07 | 2002-06-07 | Aamic Ab | Micro-fluid structures |
US20040127489A1 (en) | 2002-07-29 | 2004-07-01 | David Pickar | Novel antipsychotic combination therapies and compositions useful therein |
AU2003264915A1 (en) | 2002-08-05 | 2004-02-25 | Eli Lilly And Company | Piperazine substituted aryl benzodiazepines |
US20040193446A1 (en) * | 2003-03-27 | 2004-09-30 | Mayer Steven Lloyd | System and method for managing a patient treatment program including a prescribed drug regimen |
KR101412271B1 (ko) | 2003-05-09 | 2014-06-25 | 듀크 유니버시티 | Cd20-특이적 항체 및 이를 이용한 방법 |
BRPI0413595B8 (pt) * | 2003-08-18 | 2021-05-25 | H Lundbeck As | sal de malonato, composição farmacêutica, uso de um sal de malonato, e, método de fabricação de um composto |
JP2007505864A (ja) | 2003-09-23 | 2007-03-15 | フェルミオン オサケ ユキチュア | クエチアピンの製造 |
NZ546834A (en) | 2003-10-01 | 2010-03-26 | Adolor Corp | Spirocyclic heterocyclic derivatives and methods of their use |
WO2005059547A2 (en) * | 2003-12-12 | 2005-06-30 | Inverness Medical Switzerland Gmbh | Assay |
SE0400662D0 (sv) | 2004-03-24 | 2004-03-24 | Aamic Ab | Assay device and method |
JP4943144B2 (ja) | 2004-04-26 | 2012-05-30 | 松山 隆美 | 葉酸リセプターベータ(FR−β)に対する単クローン抗体を含有する治療薬 |
SE527036C2 (sv) | 2004-06-02 | 2005-12-13 | Aamic Ab | Analysanordning med reglerat flöde och motsvarande förfarande |
TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
US20060235005A1 (en) | 2005-04-14 | 2006-10-19 | Oak Labs, Corp. | Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia |
US7803319B2 (en) * | 2005-04-29 | 2010-09-28 | Kimberly-Clark Worldwide, Inc. | Metering technique for lateral flow assay devices |
SE529254C2 (sv) | 2005-06-17 | 2007-06-12 | Aamic Ab | Optiskt testsystem |
SE0501418L (sv) | 2005-06-20 | 2006-09-26 | Aamic Ab | Metod och medel för att åstadkomma vätsketransport |
EP1933814A2 (en) * | 2005-09-15 | 2008-06-25 | Elan Pharma International Limited | Nanoparticulate aripiprazole formulations |
SE529711C2 (sv) | 2006-03-22 | 2007-11-06 | Aamic Ab | Fluorescensläsare |
US8975374B2 (en) | 2006-10-20 | 2015-03-10 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient |
JP5450092B2 (ja) | 2006-12-29 | 2014-03-26 | アボット・ラボラトリーズ | 全血中の分子または薬物の検出のための診断検査 |
FR2918664B1 (fr) | 2007-07-11 | 2009-10-02 | Commissariat Energie Atomique | Reactif pseudo peptidique trifonctionnel, ses utilisations et applications. |
AU2008303540B2 (en) | 2007-09-27 | 2012-04-26 | Novartis Ag | Drug monitoring assay |
US8133743B2 (en) | 2007-10-19 | 2012-03-13 | Roche Diagnostics Operations, Inc. | Phenobarbital derivatives useful in immunoassay |
JP5828762B2 (ja) | 2008-07-21 | 2015-12-09 | プロビオドルグ エージー | 診断用抗体アッセイ |
EP2331088A4 (en) * | 2008-08-06 | 2011-10-12 | Gosforth Ct Holdings Pty Ltd | COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES |
US20100069356A1 (en) | 2008-09-17 | 2010-03-18 | Auspex Pharmaceuticals, Inc. | Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors |
EP2350077B1 (en) | 2008-10-14 | 2016-01-27 | Entasis Therapeutics Limited | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
US20100144781A1 (en) * | 2008-10-29 | 2010-06-10 | Dong-Jing Fu | Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene |
EP2194048A1 (en) | 2008-12-02 | 2010-06-09 | Dirk Sartor | Nitrate esters for the treatment of vascular and metabolic diseases |
US8480333B2 (en) | 2008-12-26 | 2013-07-09 | Steven Edward DeMay | Frame rail assemblies and interlocking frame rail systems |
WO2010083843A1 (en) * | 2009-01-26 | 2010-07-29 | Egalet A/S | Controlled release formulations with continuous efficacy |
DK2406288T3 (en) | 2009-03-10 | 2017-03-27 | Baylor Res Inst | ANTIGEN PRESENTING CELL-TARGETED VACCINES |
EP2261259B1 (en) * | 2009-06-10 | 2014-07-30 | Randox Laboratories Ltd. | Immunoassay for N-(3-chlorophenyl)piperazine-based anti-depressants |
GB0910031D0 (en) * | 2009-06-11 | 2009-07-22 | Randox Lab Ltd | Mcpp immunoassay |
CA2766033C (en) | 2009-06-25 | 2016-09-20 | Alkermes, Inc. | Prodrugs of nh-acidic compounds |
CA2769162C (en) | 2009-07-31 | 2017-12-05 | Ascendis Pharma As | Biodegradable polyethylene glycol based water-insoluble hydrogels |
US8076097B2 (en) | 2009-08-19 | 2011-12-13 | Saladax Biomedical Inc. | Imatinib immunoassay |
US20130053405A1 (en) | 2009-10-06 | 2013-02-28 | Ulrich Hersel | Carrier linked paliperidone prodrugs |
EP2343296A1 (en) | 2009-12-01 | 2011-07-13 | Chemo Ibérica, S.A. | A process for the purification of paliperidone |
CN102781236B (zh) | 2009-12-31 | 2015-01-07 | 凯姆制药公司 | 喹硫平的氨基酸缀合物、其制备和使用方法 |
DK2544536T3 (en) | 2010-03-11 | 2019-02-04 | Kempharm Inc | FAT ACID CONJUGATES OF QUETIAPIN, METHOD OF PREPARING IT AND USING IT |
US8088594B2 (en) * | 2010-03-16 | 2012-01-03 | Saladax Biomedical Inc. | Risperidone immunoassay |
CN102260290A (zh) | 2010-05-25 | 2011-11-30 | 苏州波锐生物医药科技有限公司 | 喹喏啉酮类化合物及其在制备精神病药物中的用途 |
WO2011159537A2 (en) | 2010-06-15 | 2011-12-22 | The Regents Of The University Of California | Method and device for analyte detection |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
JP5848761B2 (ja) * | 2010-06-24 | 2016-01-27 | アルカーメス ファーマ アイルランド リミテッド | Nh酸性化合物のプロドラッグ:エステル、カルボネート、カルバメートおよびホスホネートの誘導体 |
US9156822B2 (en) * | 2010-07-02 | 2015-10-13 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine D2 receptors |
US8623324B2 (en) | 2010-07-21 | 2014-01-07 | Aat Bioquest Inc. | Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
WO2013024047A1 (en) | 2011-08-12 | 2013-02-21 | Ascendis Pharma A/S | High-loading water-soluble carrier-linked prodrugs |
CA2843503C (en) | 2011-08-12 | 2020-12-22 | Ulrich Hersel | Polymeric hyperbranched carrier-linked prodrugs |
CA2858787C (en) | 2011-12-15 | 2017-11-21 | Alkermes Pharma Ireland Limited | Prodrugs of tertiary amine compounds |
WO2013123236A1 (en) * | 2012-02-14 | 2013-08-22 | Purdue Pharma L.P. | Systems and methods to quantify analytes in keratinized samples |
CA2882038A1 (en) | 2012-08-16 | 2014-02-20 | Janssen Pharmaceutica Nv | Substituted pyrazoles as n-type calcium channel blockers |
CA2882615C (en) | 2012-08-21 | 2019-07-09 | Ortho-Clinical Diagnostics, Inc. | Antibodies to quetiapine and use thereof |
JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
TR201816416T4 (tr) | 2012-08-21 | 2018-11-21 | Janssen Pharmaceutica Nv | Risperidona yönelik antikorlar ve bunların kullanımı. |
CN104755928B (zh) | 2012-08-21 | 2017-05-10 | 詹森药业有限公司 | 奥氮平的抗体及其用途 |
CN104736567B (zh) * | 2012-08-21 | 2019-09-03 | 詹森药业有限公司 | 阿立哌唑半抗原的抗体及其用途 |
WO2014031665A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to quetiapine haptens and use thereof |
JP6131415B2 (ja) | 2012-08-21 | 2017-05-24 | ヤンセン ファーマシューティカ エヌ.ベー. | イムノアッセイに使用するためのクエチアピンのハプテン |
CN104755479B (zh) | 2012-08-21 | 2016-11-09 | 詹森药业有限公司 | 利培酮和帕潘立酮的半抗原 |
EP3556759B1 (en) | 2012-08-21 | 2023-11-29 | Janssen Pharmaceutica NV | Haptens of paliperidone |
CA2882490A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc. | Antibodies to paliperidone and use thereof |
JP6374387B2 (ja) | 2012-08-21 | 2018-08-15 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドンハプテンへの抗体及びその使用 |
ES2762105T3 (es) | 2012-08-21 | 2020-05-22 | Janssen Pharmaceutica Nv | Anticuerpos para aripiprazol y uso de los mismos |
PT2888269T (pt) | 2012-08-21 | 2019-01-17 | Janssen Pharmaceutica Nv | Haptenos de olanzapina |
US20140057303A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Antibodies to Olanzapine Haptens and Use Thereof |
PT2888234T (pt) * | 2012-08-21 | 2018-02-22 | Janssen Pharmaceutica Nv | Haptenos de aripiprazol e seu uso em imunoensaios |
US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
-
2013
- 2013-08-20 CN CN201380054988.3A patent/CN104736567B/zh active Active
- 2013-08-20 JP JP2015528586A patent/JP6389176B2/ja active Active
- 2013-08-20 AU AU2013305970A patent/AU2013305970B2/en not_active Ceased
- 2013-08-20 CA CA2882492A patent/CA2882492C/en active Active
- 2013-08-20 US US13/971,429 patent/US9611332B2/en active Active
- 2013-08-20 EP EP13830412.6A patent/EP2888285B1/en active Active
- 2013-08-20 WO PCT/US2013/055780 patent/WO2014031635A1/en active Application Filing
- 2013-08-20 CN CN201910154717.4A patent/CN110054694B/zh active Active
-
2015
- 2015-12-30 HK HK15112824.0A patent/HK1211955A1/zh unknown
-
2017
- 2017-03-30 US US15/474,900 patent/US10488401B2/en active Active
- 2017-03-30 US US15/474,881 patent/US10379105B2/en active Active
- 2017-11-16 AU AU2017261581A patent/AU2017261581B2/en not_active Ceased
-
2018
- 2018-08-16 JP JP2018153241A patent/JP6726715B2/ja active Active
-
2019
- 2019-07-12 US US16/510,109 patent/US11105793B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN110054694B (zh) | 2024-02-20 |
WO2014031635A1 (en) | 2014-02-27 |
EP2888285A1 (en) | 2015-07-01 |
CN104736567B (zh) | 2019-09-03 |
US10379105B2 (en) | 2019-08-13 |
AU2017261581B2 (en) | 2019-10-03 |
JP2019004890A (ja) | 2019-01-17 |
CN104736567A (zh) | 2015-06-24 |
EP2888285B1 (en) | 2024-04-17 |
AU2013305970B2 (en) | 2017-08-17 |
US11105793B2 (en) | 2021-08-31 |
JP2015529200A (ja) | 2015-10-05 |
US9611332B2 (en) | 2017-04-04 |
US20140057299A1 (en) | 2014-02-27 |
CN110054694A (zh) | 2019-07-26 |
AU2013305970A1 (en) | 2015-03-12 |
US20190331663A1 (en) | 2019-10-31 |
US10488401B2 (en) | 2019-11-26 |
CA2882492A1 (en) | 2014-02-27 |
US20180149637A1 (en) | 2018-05-31 |
AU2017261581A1 (en) | 2017-12-07 |
JP6389176B2 (ja) | 2018-09-12 |
CA2882492C (en) | 2019-05-28 |
JP6726715B2 (ja) | 2020-07-22 |
EP2888285A4 (en) | 2016-08-17 |
US20170204198A1 (en) | 2017-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1211955A1 (zh) | 阿立呱唑半抗原的抗體及其用途 | |
HK1211957A1 (zh) | 利培酮半抗原的抗體及其用途 | |
HK1211989A1 (zh) | 阿立呱唑的抗體及其用途 | |
HK1211959A1 (zh) | 喹硫平半抗原的抗體及其用途 | |
HK1255295A1 (zh) | 阿立哌唑半抗原及其在免疫測定中的應用 | |
IL238559B (en) | Antibodies against ceacam5 and their use | |
HK1211857A1 (zh) | 奧氮平半抗原的抗體及其用途 | |
HK1211956A1 (zh) | 帕潘立酮半抗原的抗體及其用途 | |
HK1212034A1 (zh) | 利培酮的抗體及其用途 | |
HK1211958A1 (zh) | 帕潘立酮的抗體及其用途 | |
HK1212033A1 (zh) | 奧氮平的抗體及其用途 |